A Vaccine to Lower Dementia Risk May Be Coming. Would You Take It?
Summary
A new study found that most Americans over 50 would be interested in a vaccine that cuts the chance of getting dementia by half. The study showed that 72% would likely get such a vaccine, while 21% were unsure, and 7% would not. Willingness to get the vaccine varied by age, gender, and race.Key Facts
- The study surveyed over 1,500 Americans aged 50 and older.
- It focused on a low-cost, multi-dose vaccine that could reduce dementia risk by 50%.
- 72% said they would likely or definitely get the vaccine.
- 21% were unsure about receiving the vaccine.
- 7% said they likely or definitely would not get the vaccine.
- People aged 70 and older were slightly more willing than those in their 50s.
- Women were more hesitant than men to accept the vaccine.
- Black Americans showed more hesitation compared to White Americans.
- Researchers noted that uncertainty about the vaccine was more common than outright refusal.
- Previous studies have shown some existing vaccines, like the shingles vaccine, might be linked to lower dementia risk.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
